Patent Assignment
Reel/Frame 039835/0245
Assignment of Assignor's Interest
Recorded: 2016-09-22
Pages: 11
Assignors
BLANKENSHIP, JOHN
Executed: 2015-04-02
LOWE, RICHARD
Executed: 2015-03-25
SEWELL, ELAINE
Executed: 2015-03-24
Assignee
EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
2401 4TH AVENUE, SUITE 1050, SEATTLE, WASHINGTON, 98121
Covered Property
(1)
Cell Line-Based Redirected T-Cell Cytotoxicity Assay
Application:
15/126,922 →
Publication:
US 2017/0089885
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Sep 28, 2016
From: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
To: APTEVO RESEARCH AND DEVELOPMENT LLC
Reel/Frame 040169/0990 →
Security Interest
Feb 7, 2019
From: APTEVO THERAPEUTICS INC.; APTEVO BIOTHERAPEUTICS INC.; APTEVO RESEARCH AND DEVELOPMENT LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 048270/0813 →
Release of Security Interest
Mar 6, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: APTEVO THEAPEUTICS INC.; APTEVO BIOTHERAPEUTICS LLC; APTEVO RESEARCH AND DEVELOPMENT LLC
Reel/Frame 052039/0258 →